A quick hands-on proof of concept shows how Visual Studio's new custom-agent framework can be aimed at a real Blazor project, along with what else is new in the March update.
In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions. By Rebecca ...
Indian firms such as Ajanta Pharma, Dr Reddy's Laboratories, Lupin, Mankind Pharma and Sun Pharmaceuticals are poised to fulfil domestic demand for weight-loss drugs with more affordable generic ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Ozempic and Wegovy are injectable prescription weight-loss medicines made by Danish ...
Lantheus has filed what it says is the first generic version of Novartis’ big-selling cancer radionuclide therapy Lutathera in the US, used to treat rare neuroendocrine tumours (NETs). The FDA has ...
With patents expiring today in India for Novo Nordisk’s popular diabetes and obesity drugs Ozempic and Wegovy, more than 40 generic drug makers are expected to begin launching their cheaper versions ...
Efforts by Amazon to disrupt the healthcare sector just stepped up a gear, with the launch of a subscription service for Prime members that will ship generic medicines to patients' homes in return for ...
Actress and hands-on mom Judy Ann Santos, together with her mother, Mommy Carol, headlines the campaign—underscoring the multi-generational trust in TGP Generics. TGP reminds Filipinos why it remains ...
The Democratic Party continues to lead over Republicans in the battle to control the House of Representatives, but by a slimmer margin than two months ago. The latest Rasmussen Reports national ...
Cequa is a brand-name eye drop prescribed for dry eye. Cequa contains the active ingredient cyclosporine and is a type of immunosuppressant. The most commonly reported side effects of Cequa are eye ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results